Immune system both shields as well as promotes tumour growthSeptember 30th, 2008 - 1:45 pm ICT by ANI
London, Sept 30 (ANI): In a new study, researchers at the University of Pennsylvania School of Medicine have discovered that some proteins of the immune system can promote tumor growth.
According to John D. Lambris, PhD, the protein C5a, which is produced during an immune response to a developing tumour, helps tumours build molecular shields against T-cell attack.
C5a belongs to the complement system, one of the bodys immune defenses against pathogens. If the system proteins get activated they can relieve the body of microbes and foreign cells.
In fact, a large number of cancer treatments are aimed at boosting the immune system to kill tumours.
Until now, everyone thought that the complement system was there to eliminate tumor cells. We found that in some conditions, the complement system can promote tumor growth, depending on the specific tumor and the specific environment in which the tumors are developing, Nature quoted Lambris as saying
But, the scientists discovered that in a mouse model, activation of the complement system in tumour tissue leads to the generation of C5a.
C5a then ropes in myeloid-derived suppressor cells (MDSC) to tumours. The MDSCs block the function of CD8+ T cells, which would normally dismantle a tumour.
The scientists also found that blocking the C5a receptor on cell surfaces impairs tumour growth at the same rate of Paclitaxel, a chemotherapy drug.
The discovery could lead to new cancer treatments with far fewer side effects than chemotherapy.
Researchers are trying to introduce immune therapies and anti-tumor vaccines, but most of these vaccines fail. We show in this study a possible mechanism how to overcome this problem, said Lambris.
The researchers are conducting studies that utilise the approaches described in this paper to five models of cancer.
The findings appeared online in Nature Immunology. (ANI)
- Blocking immune system protein can hasten newer cancer treatments - Sep 30, 2008
- Smoking cannabis 'ups cancer risk' - Nov 25, 2010
- Marijuana raises risk of cancer, other killer diseases - Nov 25, 2010
- Scientists use patient's tumor to form cancer vaccine - Nov 25, 2010
- Structure of immune system's key molecule offers clues for designing drugs - Dec 28, 2010
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- How cannabis dampens the body's immune system - Dec 04, 2010
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- New research brings cancer vaccine a step closer - Nov 05, 2010
- 'Immune profile' may guide chemotherapy for breast cancer - Apr 04, 2011
- New study shows evidence of stem cells' pivotal role in cancer - Dec 22, 2010
- New cancer drug may end chemo misery - Oct 10, 2010
- Scientists identify molecules that help propel cancer metastasis - Apr 09, 2011
Tags: according to john, boosting the immune system, c5a, cd8 t cells, cell surfaces, chemotherapy drug, complement system, immune defenses, immune therapies, lambris, mouse model, nature immunology, new cancer treatments, paclitaxel, pennsylvania school, suppressor cells, system proteins, tumor cells, tumor growth, university of pennsylvania school of medicine